glp-1 obesity drug news today oct 23 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Weight-Loss Boom Linked To
Description
Designed to complement your GLP-1 journey
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Learn the expert-approved nutrition plan that helps reduce side effects and keeps weight off for good.
Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Available for both RF and RM licensing.
